Ritika Jankar/LinkedIn
May 18, 2026, 13:10
Ritika Jankar: Hemophilia Market Size to Reach USD 23.46 Billion by 2035
Ritika Jankar, Search Engine Optimization Executive at Precedence Research, shared on LinkedIn:
”Hemophilia Market Size to Reach USD 23.46 Billion by 2035
According to industry insights, the global hemophilia market size was valued at USD 12.50 billion in 2025 and is projected to reach approximately USD 23.46 billion by 2035, expanding at a CAGR of 6.50% during the forecast period.
Key Growth Factors Driving the Hemophilia Market
- Rising diagnosis rates and awareness of bleeding disorders
- Increasing adoption of prophylactic therapies
- Rapid advancements in gene and cell therapy
- Growing development of recombinant coagulation factors
- Expanding healthcare infrastructure in emerging economies
- Technological advancements in AI-driven diagnostics and patient monitoring
- Strong investments in rare disease research and innovation
Emerging Market Opportunities
- Next-generation gene therapy development
- Personalized medicine and precision healthcare
- AI-powered treatment planning and predictive analytics
- Expansion of homecare and self-administration therapies
- Increasing penetration of advanced therapies in Asia Pacific
- Development of long-acting and non-factor replacement therapies
Explore detailed market insights.”
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients